Novo Nordisk Annual Sales Jump on Demand for Ozempic and Wegovy

Novo Nordisk, the Danish pharmaceutical company behind Ozempic and Wegovy, capped off a somewhat turbulent 2024, reporting profit and revenue on Wednesday that comfortably beat Wall Street expectations. But the…

Relative of Ozempic Failed to Treat Parkinson’s Disease in Trial

The idea was so tantalizing. Drugs in the GLP-1 class, which includes Wegovy and Ozempic, have proved miraculous in treating weight loss and other diseases. And some researchers hoped that…

Medicare to Negotiate Lower Prices for Weight-Loss Drugs

Medicare’s prices for the blockbuster weight-loss drugs Ozempic and Wegovy are likely to decline starting in 2027, thanks to their inclusion on a list of medicines whose prices will be…

New Obesity Definition Challenges Current Use of B.M.I.

Obesity should be assessed in a way that goes beyond the standard measure of body mass index, or B.M.I., according to a new definition of the condition released by an…